These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32321997)

  • 1. Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
    Li MM; Chao E; Esplin ED; Miller DT; Nathanson KL; Plon SE; Scheuner MT; Stewart DR;
    Genet Med; 2020 Jul; 22(7):1142-1148. PubMed ID: 32321997
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidental detection of acquired variants in germline genetic and genomic testing: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
    Chao EC; Astbury C; Deignan JL; Pronold M; Reddi HV; Weitzel JN;
    Genet Med; 2021 Jul; 23(7):1179-1184. PubMed ID: 33864022
    [No Abstract]   [Full Text] [Related]  

  • 3. Points to consider in the detection of germline structural variants using next-generation sequencing: A statement of the American College of Medical Genetics and Genomics (ACMG).
    Raca G; Astbury C; Behlmann A; De Castro MJ; Hickey SE; Karaca E; Lowther C; Riggs ER; Seifert BA; Thorland EC; Deignan JL;
    Genet Med; 2023 Feb; 25(2):100316. PubMed ID: 36507974
    [No Abstract]   [Full Text] [Related]  

  • 4. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
    Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
    [No Abstract]   [Full Text] [Related]  

  • 5. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Chung WK; Gordon AS; Herman GE; Klein TE; Stewart DR; Amendola LM; Adelman K; Bale SJ; Gollob MH; Harrison SM; Hershberger RE; McKelvey K; Richards CS; Vlangos CN; Watson MS; Martin CL;
    Genet Med; 2021 Aug; 23(8):1381-1390. PubMed ID: 34012068
    [No Abstract]   [Full Text] [Related]  

  • 6. Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
    Deignan JL; Chao E; Gannon JL; Greely HT; Hagman KDF; Mao R; Topper S;
    Genet Med; 2020 Aug; 22(8):1285-1287. PubMed ID: 32404921
    [No Abstract]   [Full Text] [Related]  

  • 7. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
    Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Rehder C; Bean LJH; Bick D; Chao E; Chung W; Das S; O'Daniel J; Rehm H; Shashi V; Vincent LM;
    Genet Med; 2021 Aug; 23(8):1399-1415. PubMed ID: 33927380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Points to consider to avoid unfair discrimination and the misuse of genetic information: A statement of the American College of Medical Genetics and Genomics (ACMG).
    Seaver LH; Khushf G; King NMP; Matalon DR; Sanghavi K; Vatta M; Wees K;
    Genet Med; 2022 Mar; 24(3):512-520. PubMed ID: 35253645
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Gordon AS; Amendola LM; Adelman K; Bale SJ; Chung WK; Gollob MH; Harrison SM; Herman GE; Hershberger RE; Klein TE; McKelvey K; Richards CS; Vlangos CN; Stewart DR; Watson MS; Martin CL;
    Genet Med; 2021 Aug; 23(8):1391-1398. PubMed ID: 34012069
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
    ACMG Board of Directors
    Genet Med; 2019 Jul; 21(7):1467-1468. PubMed ID: 31019278
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
    David KL; Best RG; Brenman LM; Bush L; Deignan JL; Flannery D; Hoffman JD; Holm I; Miller DT; O'Leary J; Pyeritz RE;
    Genet Med; 2019 Apr; 21(4):769-771. PubMed ID: 30578420
    [No Abstract]   [Full Text] [Related]  

  • 13. DNA-based screening and population health: a points to consider statement for programs and sponsoring organizations from the American College of Medical Genetics and Genomics (ACMG).
    Murray MF; Giovanni MA; Doyle DL; Harrison SM; Lyon E; Manickam K; Monaghan KG; Rasmussen SA; Scheuner MT; Palomaki GE; Watson MS;
    Genet Med; 2021 Jun; 23(6):989-995. PubMed ID: 33727704
    [No Abstract]   [Full Text] [Related]  

  • 14. DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG).
    Bean LJH; Scheuner MT; Murray MF; Biesecker LG; Green RC; Monaghan KG; Palomaki GE; Sharp RR; Trotter TL; Watson MS; Powell CM;
    Genet Med; 2021 Jun; 23(6):979-988. PubMed ID: 33790423
    [No Abstract]   [Full Text] [Related]  

  • 15. Points to consider in the practice of postmortem genetic testing: A statement of the American College of Medical Genetics and Genomics (ACMG).
    Deignan JL; De Castro M; Horner VL; Johnston T; Macaya D; Maleszewski JJ; Reddi HV; Tayeh MK;
    Genet Med; 2023 May; 25(5):100017. PubMed ID: 36799919
    [No Abstract]   [Full Text] [Related]  

  • 16. Correspondence on "Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)" by Hanson et al.
    Stern RH
    Genet Med; 2024 Feb; 26(2):101031. PubMed ID: 38156989
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical, technical, and environmental biases influencing equitable access to clinical genetics/genomics testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
    Matalon DR; Zepeda-Mendoza CJ; Aarabi M; Brown K; Fullerton SM; Kaur S; Quintero-Rivera F; Vatta M;
    Genet Med; 2023 Jun; 25(6):100812. PubMed ID: 37058144
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic testing for inherited colorectal cancer and polyposis, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Mao R; Krautscheid P; Graham RP; Ganguly A; Shankar S; Ferber M; Hegde M;
    Genet Med; 2021 Oct; 23(10):1807-1817. PubMed ID: 34140662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correspondence on "Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)" by Riggs et al.
    Spurdle AB; Drackley A; Ing A; Tudini E; Yap KL; Tavtigian SV
    Genet Med; 2023 Aug; 25(8):100868. PubMed ID: 37261439
    [No Abstract]   [Full Text] [Related]  

  • 20. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
    Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
    Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.